Ventoux Biosciences
Pre-clinicalDeveloping immune-fibrotic therapies to preserve function and improve outcomes in disease and injury
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Total funding raised: $12M
About
Developing immune-fibrotic therapies to preserve function and improve outcomes in disease and injury
CardiovascularMetabolic
Funding History
1Total raised:$12M
Seed$12MFeb 15, 2023